Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody

Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody

Characteristic symptoms of NSAID-exacerbated respiratory disease (N-ERD) include asthma, chronic eosinophilic rhinosinusitis with nasal polyposis, cysteinyl LT (CysLT) overproduction and NSAIDs hypersensitivity. Some N-ERD patients present with episodic treatment-resistant extra-respiratory symptoms...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroaki Hayashi, Makoto Ishii, Yoshinori Hasegawa, Masami Taniguchi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Allergology International
Subjects:
Leukotriene E4
Mast cell
NSAID-exacerbated respiratory disease (N-ERD)
Omalizumab
Respiratory and extra-respiratory symptom
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893024001084
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items